Side-by-Side Comparison
| Metric | Biorasis Inc. | Glycobond |
|---|---|---|
| Founded | 2007 | 2011 |
| Headquarters | Mansfield, United States | Linkoping, Sweden |
| Employees | 9 | 1 |
| Industry | Biotechnology, Health Care, IT | Biotechnology, Health Care |
| Funding Stage | Unknown | Grant |
| Total Funding | $3.59M | $50.00K |
| Funding Rounds | 3 | 3 |
| Business Model | Not tracked yet | Not tracked yet |
| Revenue Model | Not tracked yet | Not tracked yet |
| Services | Not tracked yet | Not tracked yet |
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | Real-time Monitoring, Wireless Sensor Technology, Continuous Glucose Monitoring, Bio-analyte Monitoring, Miniaturized Sensor Platform, Cardiovascular Diagnostics, Cancer Diagnostics, Liver Function Monitoring, Kidney Function Monitoring, Stroke Monitoring, Epilepsy Monitoring, Implantable Sensors, UCONN Collaboration, OSCI Technology | Medical Diagnostics, Cancer Diagnosis, Liver Diseases, Carbohydrate-binding Peptides, Recombinant Technology, CE-marked Assay, HCC Diagnosis, Liver Cancer Monitoring |
| Website | bio-orasis.com | glycobond.com |
About Biorasis Inc.
Biorasis Inc., founded in December 2007, is at the forefront of developing cutting-edge, real-time, wireless sensor technology designed for continuous glucose and bio-analyte monitoring. With its origins in research at UCONN and OSCI, the company has developed a miniaturized sensor platform that is...
About Glycobond
Glycobond is a biotechnology startup based in Sweden that utilizes recombinant technology to produce carbohydrate-binding peptides for the diagnosis and monitoring of liver diseases and cancer. Their flagship product, HepaCheC®, is a CE-marked assay designed to aid in the diagnosis of primary liver...
Frequently Asked Questions
Track both companies in real time
Signal Tracker monitors Biorasis Inc., Glycobond, and millions of companies for 40+ signal types.